Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Increased risk of morbidities and health-care utilisation in children born following preterm labour compared with full-term labour: A population-based study.

Houben E, Smits E, Pimenta JM, Black LK, Bezemer ID, Penning-van Beest FJ.

J Paediatr Child Health. 2019 Apr;55(4):446-453. doi: 10.1111/jpc.14225. Epub 2018 Oct 4.

PMID:
30288825
2.

Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.

Heintjes EM, Overbeek JA, Hall GC, Prieto-Alhambra D, Lapi F, Hammar N, Bezemer ID.

Clin Ther. 2017 Nov;39(11):2296-2310.e14. doi: 10.1016/j.clinthera.2017.09.016. Epub 2017 Nov 4.

PMID:
29108837
3.

Thrombotic risk minimization for Diane-35 and generics.

Bezemer ID, Smits E, Penning-van Beest FJA, Asiimwe A, Herings RMC.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1411-1417. doi: 10.1002/pds.4319. Epub 2017 Sep 26.

PMID:
28952198
4.

Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project.

Poluzzi E, Diemberger I, De Ridder M, Koci A, Clo M, Oteri A, Pecchioli S, Bezemer I, Schink T, Pilgaard Ulrichsen S, Boriani G, Sturkenboom MCJ, De Ponti F, Trifirò G.

Eur J Clin Pharmacol. 2017 Nov;73(11):1499-1510. doi: 10.1007/s00228-017-2317-0. Epub 2017 Aug 22.

PMID:
28831527
5.

Use of azithromycin and risk of ventricular arrhythmia.

Trifirò G, de Ridder M, Sultana J, Oteri A, Rijnbeek P, Pecchioli S, Mazzaglia G, Bezemer I, Garbe E, Schink T, Poluzzi E, Frøslev T, Molokhia M, Diemberger I, Sturkenboom MCJM.

CMAJ. 2017 Apr 18;189(15):E560-E568. doi: 10.1503/cmaj.160355.

6.

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.

Overbeek JA, Heintjes EM, Prieto-Alhambra D, Blin P, Lassalle R, Hall GC, Lapi F, Bianchini E, Hammar N, Bezemer ID, Herings RMC.

Clin Ther. 2017 Apr;39(4):759-770. doi: 10.1016/j.clinthera.2017.02.008. Epub 2017 Mar 23.

PMID:
28342563
7.

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.

Kuiper JG, Bezemer ID, Driessen MT, Vasylyev A, Roehrborn CG, Penning-van Beest FJ, Herings RM.

BMC Urol. 2016 Aug 31;16(1):53. doi: 10.1186/s12894-016-0170-6.

8.

Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

Oteri A, Mazzaglia G, Pecchioli S, Molokhia M, Ulrichsen SP, Pedersen L, Poluzzi E, De Ponti F, Garbe E, Schink T, Herings R, Bezemer ID, Sturkenboom MC, Trifirò G.

Br J Clin Pharmacol. 2016 Aug;82(2):487-97. doi: 10.1111/bcp.12955. Epub 2016 May 18. Erratum in: Br J Clin Pharmacol. 2017 Jun;83(6):1360.

9.

Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.

Coloma PM, de Ridder M, Bezemer I, Herings RM, Gini R, Pecchioli S, Scotti L, Rijnbeek P, Mosseveld M, van der Lei J, Trifirò G, Sturkenboom M; EU-ADR Consortium.

Osteoporos Int. 2016 May;27(5):1857-67. doi: 10.1007/s00198-015-3441-2. Epub 2015 Dec 22.

10.

Factors Associated with T2DM Treatment Choice Across Europe.

Overbeek JA, Heintjes EM, Hall GC, Lapi F, Prieto Alhambra D, Bezemer ID.

Value Health. 2015 Nov;18(7):A600. doi: 10.1016/j.jval.2015.09.2057. Epub 2015 Oct 20. No abstract available.

11.

Anticoagulant Treatment After Vte In The Netherlands.

Bezemer ID, Folkerts K, van den Berg E, Bamber L, Penning-van Beest FJ, Herings RM, Coppens M.

Value Health. 2015 Nov;18(7):A403. doi: 10.1016/j.jval.2015.09.937. Epub 2015 Oct 20. No abstract available.

12.

Use of oral contraceptives in three European countries: a population-based multi-database study.

Bezemer ID, Verhamme KM, Gini R, Mosseveld M, Rijnbeek PR, Trifirò G, Sturkenboom MC, Penning-van Beest FJ, Herings RM.

Eur J Contracept Reprod Health Care. 2016;21(1):81-7. doi: 10.3109/13625187.2015.1102220. Epub 2015 Oct 22.

PMID:
26492444
13.

Erratum to: Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2016 Feb;44(1):145-50. doi: 10.1007/s15010-015-0835-1. No abstract available.

PMID:
26358972
14.

Infants born before 32 weeks of gestation or with respiratory disease are most likely to receive palivizumab in the Netherlands.

Kool-Houweling LM, Penning-van Beest FJ, Bezemer ID, van Lingen RA, Herings RM.

Acta Paediatr. 2015 Sep;104(9):927-32. doi: 10.1111/apa.13081. Epub 2015 Jul 23.

PMID:
26073782
15.

Trends in paediatric macrolide use in five European countries-a population-based study.

Holstiege J, Enders D, Schink T, Innocenti F, Oteri A, Bezemer I, Kaguelidou F, Molokhia M, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

Eur J Clin Pharmacol. 2015 Aug;71(8):991-9. doi: 10.1007/s00228-015-1870-7. Epub 2015 May 22.

PMID:
25998220
16.

Antibiotic use varies substantially among adults: a cross-national study from five European Countries in the ARITMO project.

Mor A, Frøslev T, Thomsen RW, Oteri A, Rijnbeek P, Schink T, Garbe E, Pecchioli S, Innocenti F, Bezemer I, Poluzzi E, Sturkenboom MC, Trifirò G, Søgaard M.

Infection. 2015 Aug;43(4):453-72. doi: 10.1007/s15010-015-0768-8. Epub 2015 Apr 1. Erratum in: Infection. 2016 Feb;44(1):145-50.

PMID:
25828936
17.

Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical Practice.

Brobert G, García RL, Garbe E, Bezemer ID, Layton D, Friberg L, Suzart-Woischnik K, Alderson J, Winchester C, Herings RM, Jobski K, Schink T, Shakir S, Soriano-Gabarró M, Wallander MA.

Value Health. 2014 Nov;17(7):A473-4. doi: 10.1016/j.jval.2014.08.1350. Epub 2014 Oct 26. No abstract available.

18.

Type 2 Diabetes Treatment Patterns Across Europe.

Heintjes E, Overbeek JA, Blin P, Hall GC, Lapi F, Prieto AD, Bezemer ID.

Value Health. 2014 Nov;17(7):A359. doi: 10.1016/j.jval.2014.08.779. Epub 2014 Oct 26. No abstract available.

19.

Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor.

de Haan HG, Bezemer ID, Vossen CY, van Hylckama Vlieg A, Böehringer S, Hasstedt SJ, Levy S, Rosendaal FR, Bovill EG.

Thromb Res. 2014 Dec;134(6):1186-92. doi: 10.1016/j.thromres.2014.09.018. Epub 2014 Sep 23.

20.

Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study.

Holstiege J, Schink T, Molokhia M, Mazzaglia G, Innocenti F, Oteri A, Bezemer I, Poluzzi E, Puccini A, Ulrichsen SP, Sturkenboom MC, Trifirò G, Garbe E.

BMC Pediatr. 2014 Jul 5;14:174. doi: 10.1186/1471-2431-14-174.

21.

Protein S levels and the risk of venous thrombosis: results from the MEGA case-control study.

Pintao MC, Ribeiro DD, Bezemer ID, Garcia AA, de Visser MC, Doggen CJ, Lijfering WM, Reitsma PH, Rosendaal FR.

Blood. 2013 Oct 31;122(18):3210-9. doi: 10.1182/blood-2013-04-499335. Epub 2013 Sep 6.

22.

INR control calculation: comparison of Dutch and international methods.

Bezemer ID, Roemer WH, Penning-van Beest FJ, van Eekelen E, Kramer MH.

Neth J Med. 2013 May;71(4):194-8.

23.

First year of life medication use and hospital admission rates: premature compared with term infants.

Houweling LM, Bezemer ID, Penning-van Beest FJ, Meijer WM, van Lingen RA, Herings RM.

J Pediatr. 2013 Jul;163(1):61-6.e1. doi: 10.1016/j.jpeds.2012.12.014. Epub 2013 Jan 17.

PMID:
23333133
24.

Multiple SNP testing improves risk prediction of first venous thrombosis.

de Haan HG, Bezemer ID, Doggen CJ, Le Cessie S, Reitsma PH, Arellano AR, Tong CH, Devlin JJ, Bare LA, Rosendaal FR, Vossen CY.

Blood. 2012 Jul 19;120(3):656-63. doi: 10.1182/blood-2011-12-397752. Epub 2012 May 14.

25.

Candidate gene polymorphisms and the risk for pregnancy-related venous thrombosis.

Dahm AE, Bezemer ID, Bergrem A, Jacobsen AF, Jacobsen EM, Skretting G, Rosendaal FR, Sandset PM.

Br J Haematol. 2012 Jun;157(6):753-61. doi: 10.1111/j.1365-2141.2012.09121.x. Epub 2012 Apr 26.

PMID:
22533697
26.

Genetic variants of F11, statin use and venous thrombosis.

Bare LA, Arellano AR, Tong CH, Bezemer I, Lijfering WM, Devlin JJ, Reitsma PH, Rosendaal FR.

J Thromb Haemost. 2011 Jun;9(6):1249-51. doi: 10.1111/j.1538-7836.2011.04289.x. No abstract available.

27.

New gene variants associated with venous thrombosis: a replication study in White and Black Americans.

Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, Hooper WC.

J Thromb Haemost. 2011 Mar;9(3):489-95. doi: 10.1111/j.1538-7836.2011.04185.x.

28.

A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1.

Morange PE, Bezemer I, Saut N, Bare L, Burgos G, Brocheton J, Durand H, Biron-Andreani C, Schved JF, Pernod G, Galan P, Drouet L, Zelenika D, Germain M, Nicaud V, Heath S, Ninio E, Delluc A, Münzel T, Zeller T, Brand-Herrmann SM, Alessi MC, Tiret L, Lathrop M, Cambien F, Blankenberg S, Emmerich J, Trégouët DA, Rosendaal FR.

Am J Hum Genet. 2010 Apr 9;86(4):592-5. doi: 10.1016/j.ajhg.2010.02.011. Epub 2010 Mar 11. Erratum in: Am J Hum Genet. 2010 Apr 9;86(4):655.

29.

Interaction between tissue factor pathway inhibitor and factor V levels on the risk of venous thrombosis.

Dahm AE, Bezemer ID, Sandset PM, Rosendaal FR.

J Thromb Haemost. 2010 May;8(5):1130-2. doi: 10.1111/j.1538-7836.2010.03805.x. Epub 2010 Feb 11. No abstract available.

30.

Gene variants associated with venous thrombosis: confirmation in the MEGA study.

Arellano AR, Bezemer ID, Tong CH, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR.

J Thromb Haemost. 2010 May;8(5):1132-4. doi: 10.1111/j.1538-7836.2010.03782.x. Epub 2010 Jan 30. No abstract available.

31.

Updated analysis of gene variants associated with deep vein thrombosis.

Bezemer ID, Bare LA, Arellano AR, Reitsma PH, Rosendaal FR.

JAMA. 2010 Feb 3;303(5):421-2. doi: 10.1001/jama.2010.57. No abstract available.

PMID:
20124536
32.

Cell adhesion molecule 1: a novel risk factor for venous thrombosis.

Hasstedt SJ, Bezemer ID, Callas PW, Vossen CY, Trotman W, Hebbel RP, Demers C, Rosendaal FR, Bovill EG.

Blood. 2009 Oct 1;114(14):3084-91. doi: 10.1182/blood-2009-05-219485. Epub 2009 Jul 30.

33.

Genetic variants associated with deep vein thrombosis: the F11 locus.

Li Y, Bezemer ID, Rowland CM, Tong CH, Arellano AR, Catanese JJ, Devlin JJ, Reitsma PH, Bare LA, Rosendaal FR.

J Thromb Haemost. 2009 Nov;7(11):1802-8. doi: 10.1111/j.1538-7836.2009.03544.x. Epub 2009 Jul 6.

34.

The value of family history as a risk indicator for venous thrombosis.

Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ.

Arch Intern Med. 2009 Mar 23;169(6):610-5. doi: 10.1001/archinternmed.2008.589.

PMID:
19307525
35.

F9 Malmö, factor IX and deep vein thrombosis.

Bezemer ID, Arellano AR, Tong CH, Rowland CM, Ireland HA, Bauer KA, Catanese J, Reitsma PH, Doggen CJ, Devlin JJ, Rosendaal FR, Bare LA.

Haematologica. 2009 May;94(5):693-9. doi: 10.3324/haematol.2008.003020. Epub 2009 Mar 13.

36.

Mechanisms of the factor V Leiden paradox.

van Stralen KJ, Doggen CJ, Bezemer ID, Pomp ER, Lisman T, Rosendaal FR.

Arterioscler Thromb Vasc Biol. 2008 Oct;28(10):1872-7. doi: 10.1161/ATVBAHA.108.169524. Epub 2008 Jul 10.

PMID:
18617648
37.

Gene variants associated with deep vein thrombosis.

Bezemer ID, Bare LA, Doggen CJ, Arellano AR, Tong C, Rowland CM, Catanese J, Young BA, Reitsma PH, Devlin JJ, Rosendaal FR.

JAMA. 2008 Mar 19;299(11):1306-14. doi: 10.1001/jama.299.11.1306.

PMID:
18349091
38.

Predictive genetic variants for venous thrombosis: what's new?

Bezemer ID, Rosendaal FR.

Semin Hematol. 2007 Apr;44(2):85-92. Review.

PMID:
17433900
39.

No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.

Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR.

Arch Intern Med. 2007 Mar 12;167(5):497-501.

PMID:
17353498
40.

Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition.

Rinaldi S, Peeters PH, Bezemer ID, Dossus L, Biessy C, Sacerdote C, Berrino F, Panico S, Palli D, Tumino R, Khaw KT, Bingham S, Allen NE, Key T, Jensen MK, Overvad K, Olsen A, Tjonneland A, Amiano P, Ardanaz E, Agudo A, Martinez-García C, Quirós JR, Tormo MJ, Nagel G, Linseisen J, Boeing H, Schulz M, Grobbee DE, Bueno-de-Mesquita HB, Koliva M, Kyriazi G, Thrichopoulou A, Boutron-Ruault MC, Clavel-Chapelon F, Ferrari P, Slimani N, Saracci R, Riboli E, Kaaks R.

Cancer Causes Control. 2006 Oct;17(8):1033-43.

PMID:
16933054
41.

Polymorphisms in the estrogen receptor alpha gene and mammographic density.

van Duijnhoven FJ, Bezemer ID, Peeters PH, Roest M, Uitterlinden AG, Grobbee DE, van Gils CH.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2655-60.

42.

Use of hormones in the menopausal transition period in the Netherlands between 1993 and 1997.

van Duijnhoven FJ, van Gils CH, Bezemer ID, Peeters PH, van der Schouw YT, Grobbee DE.

Maturitas. 2006 Mar 20;53(4):462-75. Epub 2005 Sep 29.

PMID:
16198516
43.

C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjønneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Téhard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martínez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hémon B, Norat T, Riboli E, Kaaks R.

Cancer Causes Control. 2005 Jun;16(5):561-72.

PMID:
15986111

Supplemental Content

Loading ...
Support Center